期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脑脊液特定蛋白在散发型克雅氏病诊断中作用 被引量：3

原文传递
导出
作者 王桂荣 田婵 董小平
机构地区 中国疾病预防控制中心病毒病预防控制所朊病毒室
出处 《中国公共卫生》 CAS CSCD 北大核心 2009年第6期695-696,共2页 Chinese Journal of Public Health
基金 国家科技攻关项目(2006BAD06A13-2)
关键词 散发型克雅氏病 脑脊液 特定蛋白
分类号 R651.15 [医药卫生—外科学]
  • 相关文献

参考文献16

  • 1黄平.朊病毒分子特征与致病性[J].中国公共卫生,2002,18(10):1257-1259. 被引量：2
  • 2Verdoot B,Benzinger A, Popowicz GM, et al. 14-3-3 proteins in cell cycle regulation [ J ]. Semirl Cancer Biol,2006,16:183 - 192.
  • 3Kjarland E,Keen TJ, Kleppe R. Does isoform diversity explain functional differences in the 14-3-3 protein family[J].Curr Pharm Biotechno1,2006 ,7 :217 - 223.
  • 4Sanchez JC,Guillaume E,Lescuyer P,et al. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfelda-Jakob disease[J]. Proteomics ,2004 ,4 :2229 -2233.
  • 5Kulczycki J,Lojkowska W. The clinical and laboratory diagnosis of sCJD and vCJD[ J ]. Neurol Neurochir Pol,2003,37:7 -14.
  • 6Van Everbroeck B ,Boons J,Cras P. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease[ J]. Clin Neurol Neurosurg ,2005,107 : 355 - 360.
  • 7Buee L, Bussiere T. Buee-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders[ J ]. Braia Res Brain Res Rev ,2000,33:95 - 130.
  • 8Sjφgren M,Vanderstichele H,Agren H,et al. Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age : establishment of reference values [ J]. Clin Chem, 2001,47:101776 - 101781.
  • 9Van Everbroeck B ,Quoilin S ,Boons J,et al. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease[J]. J Neurol Neurosurg Psychiatry,2003,74 : 1210 - 1214.
  • 10Van Everbroeck B, Green AJ, Vanmechelen E, et al. Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease[ J]. J Neurol Neurosurg Psychiatry ,2002,73:79 -81.

二级参考文献55

  • 1于雪凡,林世和,赵珩.脑脊液14-3-3蛋白对不同类型Creutzfeldt-Jakob病的诊断价值[J].临床神经病学杂志,2006,19(1):77-78. 被引量：15
  • 2Boedert M. Tau protein and the neruofibrillary pathology of Alzheimer' s disease. Trends in Nenroscience, 1993; 16:460-465.
  • 3Andreasen N, Hesse C, Davidsson P, et al. Cerebrospinal fluid β-amyloid (Aβ42) in Alzheimer ' s disease; dirrferences between early-and late-onset Alzheimer disease and stability during thd course of disease. Arch Neural. 1999; 56: 673-680.
  • 4Blennow K, Wallin A, Agron H, et al. Tau protein in cerebrospinal fluid; biochemical diagnostic marker for axonal degeneration in Alzheimer' s disease. Mol Chem Neuropathology,1995; 26: 231-245.
  • 5Andreasen N, Minthon L, Clarberg A, et al.Sensitivity,specificity and stability of CSF-tau in AD in a community-based patient sample. Neurology, 1999; 53: 1488-1494.
  • 6Ishiguro K, Ohno H, Arai H, et al. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer 's disease. Neurosci Lett. 1999; 270: 91-94.
  • 7Arai H,Ishiguro K, Ohno H, et al. CSF phosphorylated tau protein and mild cognitive impairment; a prospective study.Exp Neurol. 2000; 166: 201-203.
  • 8Andreasen, Minthon L, Vanmechelen E, el al. CSF-tau anti CSF-Aβ42 as predictors of development of Alzheimer ' s disease in patients with mild cognitive impairment. Neurosci Lett, 1999; 273: 5-8.
  • 9Buerger K, Teipel SI, Zinkowski R, et al. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline im MCI subjects. Neurology, 2002; 59: 627-629.
  • 10Andreasen N, Sjogren M, Blennow K. CSF Markers for Alzheimer' s Disease; Total Tau, Phospho-tau and Aβ42.World Biol Psychiatry, 2003; 4: 147-155.

共引文献17

同被引文献25

引证文献3

二级引证文献3

中国公共卫生
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部